Coronavirus Disease 2019 in Neonates – What Is Known and What Needs to Be KnownPediatrics Published on 2020-08-312022-10-31 Journal: Cureus [Category] COVID-19, [키워드] acute respiratory syndrome affecting age Antiviral chloroquine/hydroxychloroquine coronavirus coronavirus disease Corticosteroids COVID-19 Evidence Fever Infection infection control intravenous less lethargic measure medication Neonate Newborn outcome Pneumonia pregnant women refusal Remdesivir risk of COVID-19 Ritonavir SARS CoV-2 SARS-CoV-2 Shortness of breath Spread Supportive treatment Transmission vertical transmission Wuhan, China [DOI] 10.7759/cureus.10171 PMC 바로가기 [Article Type] Pediatrics
Increase in Video Consultations During the COVID-19 Pandemic: Healthcare Professionals’ Perceptions about Their Implementation and Adequate ManagementArticle Published on 2020-07-152022-10-29 Journal: International Journal of Environmental Research an [Category] Coronavirus, SARS, [키워드] Adequate benefit Care category clinical settings clinical skills consultation COVID-19 COVID-19 pandemic Health health system healthcare healthcare providers implementation increase indicated inherent interpersonal skills lack Patient patients Perception professional professionals qualitative research refusal risk Safe Spanish Spread Support technological difficulties Telemedicine training variety Video consultation widespread [DOI] 10.3390/ijerph17145112 PMC 바로가기 [Article Type] Article
Effectiveness of Interferon Beta 1a, compared to Interferon Beta 1b and the usual therapeutic regimen to treat adults with moderate to severe COVID-19: structured summary of a study protocol for a randomized controlled trialLetter Published on 2020-06-032022-10-29 Journal: Trials [Category] Coronavirus, SARS, [키워드] 95% confidence interval Adjusted analysis Administered Admission age alcohol allocation concealment ALT/AST Analysis Arm arrhythmia assigned Beta block-randomization Blood calculated Care center clinical Clinical improvement clinical trial conducted confirmed case control group cough COVID-19 COVID-19 confirmed patient COVID-19 in patient COVID-2019 Cox proportional-hazards model death discharge disease dissemination drug Duration education Effectiveness element eligibility enrolled excluded exclusion criteria fatigue follow-up time hazard headache Health hospital hospital discharge Hospitalization Hydroxychloroquine + Lopinavir/Ritonavir improvement include Interaction Interferon beta-1a Interferon-β 1a Interferon-β 1b intervals intervention group investigator Kaletra Kaplan–Meier laboratory result lactating women Last limit log-rank test Loghman Hakim Hospital Lopinavir Lopinavir/ritonavir masking mechanical ventilation Medical Science Medical Sciences moderate Mortality myalgia nasal NCT04343768 number objective open label Open-label Other outcome oxygen saturation package parallel group participant Patient performed positive pregnant Primary outcome primary outcome measure problem professional protocol pulse-oximetry R software R version 3.6.1 randomization randomization sequence Randomized Randomized controlled trial Randomly reached receive Recigen recruitment refusal regimen Registered Research respiratory rate RT-PCR test Sample SARS-CoV-2 sealed secondary secondary outcome seven-category ordinal scale single center single dose SpO2 sputum production standard care status Study protocol Symptom temperature tested the patient therapeutic three groups time treat treated treatment groups Trial university version 3.6.1 website World Health Organization Ziferon [DOI] 10.1186/s13063-020-04382-3 PMC 바로가기 [Article Type] Letter
Logistical and structural challenges are the major obstacles for family medicine physicians’ ability to administer adult vaccinesShort Report Published on 2019-11-292024-09-04 Journal: Human vaccines & immunotherapeutics [Category] 대상포진, [키워드] CAIR chronic disease confidence EMR Family medicine FQHC healthcare logistics healthcare management immunization immunization registry insurance Los Angeles prevention Quality refusal Reimbursement resistance Structure time spent Vaccine [DOI] 10.1080/21645515.2018.1543524 PMC 바로가기 [Article Type] Short Report